Stručni rad
Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine
Zlatko Balog
Tanja Jukić-Lešina
Puni tekst: hrvatski pdf 1.685 Kb
str. 199-202
preuzimanja: 207
citiraj
APA 6th Edition
Balog, Z. i Jukić-Lešina, T. (1999). Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik, 31 ((1-4)), 199-202. Preuzeto s https://hrcak.srce.hr/index.php/191994
MLA 8th Edition
Balog, Zlatko i Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik, vol. 31, br. (1-4), 1999, str. 199-202. https://hrcak.srce.hr/index.php/191994. Citirano 10.03.2025.
Chicago 17th Edition
Balog, Zlatko i Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik 31, br. (1-4) (1999): 199-202. https://hrcak.srce.hr/index.php/191994
Harvard
Balog, Z., i Jukić-Lešina, T. (1999). 'Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine', Medicinski vjesnik, 31((1-4)), str. 199-202. Preuzeto s: https://hrcak.srce.hr/index.php/191994 (Datum pristupa: 10.03.2025.)
Vancouver
Balog Z, Jukić-Lešina T. Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik [Internet]. 1999 [pristupljeno 10.03.2025.];31((1-4)):199-202. Dostupno na: https://hrcak.srce.hr/index.php/191994
IEEE
Z. Balog i T. Jukić-Lešina, "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine", Medicinski vjesnik, vol.31, br. (1-4), str. 199-202, 1999. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/191994. [Citirano: 10.03.2025.]
Puni tekst: engleski pdf 1.685 Kb
str. 199-202
preuzimanja: 1.458
citiraj
APA 6th Edition
Balog, Z. i Jukić-Lešina, T. (1999). Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik, 31 ((1-4)), 199-202. Preuzeto s https://hrcak.srce.hr/index.php/191994
MLA 8th Edition
Balog, Zlatko i Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik, vol. 31, br. (1-4), 1999, str. 199-202. https://hrcak.srce.hr/index.php/191994. Citirano 10.03.2025.
Chicago 17th Edition
Balog, Zlatko i Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik 31, br. (1-4) (1999): 199-202. https://hrcak.srce.hr/index.php/191994
Harvard
Balog, Z., i Jukić-Lešina, T. (1999). 'Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine', Medicinski vjesnik, 31((1-4)), str. 199-202. Preuzeto s: https://hrcak.srce.hr/index.php/191994 (Datum pristupa: 10.03.2025.)
Vancouver
Balog Z, Jukić-Lešina T. Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik [Internet]. 1999 [pristupljeno 10.03.2025.];31((1-4)):199-202. Dostupno na: https://hrcak.srce.hr/index.php/191994
IEEE
Z. Balog i T. Jukić-Lešina, "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine", Medicinski vjesnik, vol.31, br. (1-4), str. 199-202, 1999. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/191994. [Citirano: 10.03.2025.]
Sažetak
Chloroquine phosphate is a 4-aminoquinoline compound widely accepted as the "second line antirheumatic drug" ("disease modifying drug", "basic drug") in the treatment of patients with rheumatoid arthritis. The original enthusiasm for this compound diminished after the recognition of serious retinal damage. We treated 24 patients during 8 (1) to 96 months (total: 643 months or in average 26,79 months) with Chlorochine in 250 mg daily doses. The ophthalmological examinations were repeatedly done every 4.5 to 5.5 months. One female patient showed transient of the first isoptere after 26 months of treatment and 1 female patient after 2 and half years of treatment was found as having perimacular bilateral pigment disgrupations. Our experience is that ocular toxicity is infrequent and can be minimized by careful and permanent ophthalmological control.
Ključne riječi
Chlorochine; Retinopathy; Rheumatoid arthritis
Hrčak ID:
191994
URI
https://hrcak.srce.hr/191994
Datum izdavanja:
1.12.1999.
Podaci na drugim jezicima:
hrvatski
Posjeta: 2.435
*
